TransMedics Group Inc vs ProShares UltraPro QQQ ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while ProShares UltraPro QQQ ETF trades at $71.48. The key difference: ProShares UltraPro QQQ ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | TQQQ | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $150.42 | $87.22 |
52-Week Low | $61.99 | $37.89 |
Enterprise Value | $2.94B | — |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →